Active Pharmacovigilance in COVID-19 Patients: The Role of a Clinical Pharmacist in the Reporting of Adverse Drug Events

被引：0
|
作者：
Hida, A. [1 ,2 ]
Faroudy, M. [1 ,3 ]
Chaibi, A. [1 ,2 ]
Cadi, M. A. E. [1 ,2 ]
机构：
[1] Mohamed V Souissi Univ, Fac Med & Pharm Rabat, Rabat, Morocco
[2] Ibn Sina Univ Hosp, Dept Pharm, Rabat, Morocco
[3] Ibn Sina Univ Hosp, Intens Care Unit, Emergency Trauma Dept, Rabat, Morocco
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P158
引用
收藏
页码：1200 / 1200
页数：1
相关论文
共 50 条
  • [1] Preventing and Reporting Adverse Drug Events Pharmacovigilance for the Clinical Nurse Specialist
    O'Malley, Patricia Anne
    [J]. CLINICAL NURSE SPECIALIST, 2012, 26 (03) : 136 - 137
  • [2] PharmaCovigilance: Role of the Pharmacist During COVID-19 Vaccination Campaign
    Martignoni, I.
    Bragantini, D.
    Cicco, P.
    Gianfilippi, G.
    Gambera, M.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1193 - 1193
  • [3] Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
    G. Fornasier
    M. Taborelli
    S. Francescon
    J. Polesel
    M. Aliberti
    P. De Paoli
    P. Baldo
    [J]. International Journal of Clinical Pharmacy, 2018, 40 : 795 - 802
  • [4] Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System
    Sun, Ji
    Deng, Xuanyu
    Chen, Xiaoping
    Huang, Juanjuan
    Huang, Siqiong
    Li, Yanfei
    Feng, Jinhui
    Liu, Jiyang
    He, Gefei
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (04) : 791 - 797
  • [5] Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
    Fornasier, G.
    Taborelli, M.
    Francescon, S.
    Polesel, J.
    Aliberti, M.
    De Paoli, P.
    Baldo, P.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (04) : 795 - 802
  • [6] Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events
    Montes-Grajales, Diana
    Garcia-Serna, Ricard
    Mestres, Jordi
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events
    Diana Montes-Grajales
    Ricard Garcia-Serna
    Jordi Mestres
    [J]. Scientific Reports, 13
  • [8] Role of Clinical Pharmacist in COVID-19 Crisis
    Damdar, Gaurav Tulshiram
    [J]. HOSPITAL PHARMACY, 2022, 57 (01) : 7 - 10
  • [9] Quality of adverse events reporting in clinical trials of COVID-19 drugs: A systematic review
    Madi, K.
    Flumian, C.
    Olivier, P.
    Sommet, A.
    Montastruc, F.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 52 - 53
  • [10] Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review
    Madi, Karima
    Flumian, Clara
    Olivier, Pascale
    Sommet, Agnes
    Montastruc, Francois
    [J]. BMJ MEDICINE, 2023, 2 (01):
12345